Longitudinal assessment of SARS-CoV-2 IgG seroconversionamong front-line healthcare workers during the first wave of the Covid-19 pandemic at a tertiary-care hospital in Chile

BMC Infect Dis. 2021 May 26;21(1):478. doi: 10.1186/s12879-021-06208-2.

Abstract

Background: Healthcare workers (HCWs) are at high risk of exposure to SARS-CoV-2. Cross-sectional studies have provided variable rates of seroprevalence in HCWs. Longitudinal assessments of the serological response to Covid-19 among HCWs are crucial to understanding the risk of infection and changes in antibody titers over time. We aimed to investigate seroprevalence and risk factors associated with seroconversion in a prospective cohort of HCWs during the peak of the first wave of the Covid-19 pandemic.

Methods: We conducted a longitudinal study among 446 front-line HCWsin a tertiary-care hospital in Chile from April to July 2020. IgG was determined monthly using two different ELISAs in serum samples of HCWs, during the three-month period. In each visit, demographic data, symptoms, risk factors, and exposure risks were also assessed.

Results: The overall seroprevalence at the end of the study period was 24% (95% CI20.2-28.3), with 43% of seropositive HCWs reporting no prior symptoms. Seroconversion rates significantly differed over the study period, from 2.1% to as high as 8.8% at the peak of the epidemic. There were no statistically significant differences observed between HCWs in direct clinical care of patients with Covid-19 and those working in low risk areas. Antibody titers appeared to wane over time.

Conclusions: HCWs were severely affected with a high rate of seroconversion that appeared to mirror the local epidemiological situation. A significant amount of participants underwent an asymptomatic infection, highlighting the need for improved surveillance policies. Antibody titers appear to wane over time; further studies to understand this finding's impact on the risk of reinfection are warranted.

Keywords: Covid-19; Healthcare workers; SARS-CoV-2; Seroconversion; Seroprevalence.

MeSH terms

  • Adult
  • Aged
  • Antibodies, Viral / blood*
  • COVID-19 / diagnosis
  • COVID-19 / epidemiology
  • COVID-19 / immunology*
  • COVID-19 Serological Testing*
  • Chile / epidemiology
  • Cohort Studies
  • Enzyme-Linked Immunosorbent Assay / methods
  • Female
  • Health Personnel / statistics & numerical data*
  • Humans
  • Immunoglobulin G / blood*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Prospective Studies
  • SARS-CoV-2 / immunology*
  • Seroconversion*
  • Seroepidemiologic Studies
  • Tertiary Care Centers

Substances

  • Antibodies, Viral
  • Immunoglobulin G